Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Should physicians give tPA to patients with acute ischemic stroke? Against: and just what is the emperor of stroke wearing?

× No keyword cloud information.

12 in total

1. Predicted impact of intravenous thrombolysis on prognosis of general population of stroke patients: simulation model.

Authors: H S Jørgensen; H Nakayama; L P Kammersgaard; H O Raaschou; T S Olsen
Journal: BMJ Date: 1999-07-31

2. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke.

Authors: W M Clark; S Wissman; G W Albers; J H Jhamandas; K P Madden; S Hamilton
Journal: JAMA Date: 1999-12-01 Impact factor: 56.272

3. Use of tissue-type plasminogen activator for acute ischemic stroke: the Cleveland area experience.

Authors: I L Katzan; A J Furlan; L E Lloyd; J I Frank; D L Harper; J A Hinchey; J P Hammel; A Qu; C A Sila
Journal: JAMA Date: 2000-03-01 Impact factor: 56.272

4. Thrombolytic therapy with streptokinase in acute ischemic stroke.

Authors: Marc Hommel; C Cornu; F Boutitie; J P Boissel
Journal: N Engl J Med Date: 1996-07-18 Impact factor: 91.245

5. Cranial computed tomography interpretation in acute stroke: physician accuracy in determining eligibility for thrombolytic therapy.

Authors: D L Schriger; M Kalafut; S Starkman; M Krueger; J L Saver
Journal: JAMA Date: 1998 Apr 22-29 Impact factor: 56.272

6. Streptokinase for acute ischemic stroke with relationship to time of administration: Australian Streptokinase (ASK) Trial Study Group.

Authors: G A Donnan; S M Davis; B R Chambers; P C Gates; G J Hankey; J J McNeil; D Rosen; E G Stewart-Wynne; R R Tuck
Journal: JAMA Date: 1996-09-25 Impact factor: 56.272

7. Tissue plasminogen activator for acute ischemic stroke.

Authors:
Journal: N Engl J Med Date: 1995-12-14 Impact factor: 91.245

8. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS)

Authors: W Hacke; M Kaste; C Fieschi; D Toni; E Lesaffre; R von Kummer; G Boysen; E Bluhmki; G Höxter; M H Mahagne
Journal: JAMA Date: 1995-10-04 Impact factor: 56.272

9. Randomised controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischaemic stroke. Multicentre Acute Stroke Trial--Italy (MAST-I) Group.

Authors:
Journal: Lancet Date: 1995-12-09 Impact factor: 79.321

Should physicians give tPA to patients with acute ischemic stroke? Against: and just what is the emperor of stroke wearing?

1. Predicted impact of intravenous thrombolysis on prognosis of general population of stroke patients: simulation model.

2. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke.

3. Use of tissue-type plasminogen activator for acute ischemic stroke: the Cleveland area experience.

4. Thrombolytic therapy with streptokinase in acute ischemic stroke.

5. Cranial computed tomography interpretation in acute stroke: physician accuracy in determining eligibility for thrombolytic therapy.

6. Streptokinase for acute ischemic stroke with relationship to time of administration: Australian Streptokinase (ASK) Trial Study Group.

7. Tissue plasminogen activator for acute ischemic stroke.

8. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS)

9. Randomised controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischaemic stroke. Multicentre Acute Stroke Trial--Italy (MAST-I) Group.

10. Conditions that mimic stroke in the emergency department. Implications for acute stroke trials.

Review 1. Alteplase for stroke: money and optimistic claims buttress the "brain attack" campaign.

2. Why were the benefits of tPA exaggerated?

Review 3. Thrombolysis in acute ischaemic stroke: a guide to patient selection.

4. What Drives Greater Assimilation of Telestroke in Emergency Departments?

5. Stroke and t-PA--Triggering New Paradigms of Care.

6. Current Drug Treatment of Acute Ischemic Stroke: Challenges and Opportunities.

Review 7. Fifty Years of Acute Ischemic Stroke Treatment: A Personal History.

8. Perceived Appropriateness of Shared Decision-making in the Emergency Department: A Survey Study.

9. A user's guide to the NINDS rt-PA stroke trial database.